The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients.
暂无分享,去创建一个
S. Loibl | G. Curigliano | A. Partridge | S. Paluch-Shimon | M. Di Maio | M. Lambertini | H. Azim | F. Poggio | L. Del Mastro | F. Peccatori | O. Pagani | I. Demeestere
[1] S. Linn,et al. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols , 2019, Fertility and Sterility.
[2] J. Cuzick,et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] S. Loibl,et al. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Ignatiadis,et al. Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status. , 2018, Journal of the National Cancer Institute.
[5] P. Neven,et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy , 2018, Breast Cancer Research and Treatment.
[6] B. van Calster,et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. , 2018, The Lancet. Oncology.
[7] M. Lambertini,et al. How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer? , 2018, Breast Cancer Research and Treatment.
[8] J. Bergh,et al. Safety of fertility preservation in breast cancer patients in a register-based matched cohort study , 2017, Breast Cancer Research and Treatment.
[9] K. Gelmon,et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). , 2017, Breast.
[10] S. Linn,et al. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial. , 2017, Contemporary clinical trials.
[11] PaganiOlivia,et al. Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. , 2017 .
[12] D. Adamson,et al. GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial , 2017, Annals of Oncology.
[13] K. Oktay,et al. Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis , 2017, Reproductive Sciences.
[14] F. Clatot,et al. Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art , 2017, Current opinion in oncology.
[15] P. Scaruffi,et al. State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature. , 2017, Cancer treatment reviews.
[16] P. Rochon,et al. Association of the Timing of Pregnancy With Survival in Women With Breast Cancer , 2017, JAMA oncology.
[17] G. Eslick,et al. The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis , 2016, Breast Cancer Research and Treatment.
[18] V. Turan,et al. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer. , 2016, The Journal of clinical endocrinology and metabolism.
[19] Alberto Revelli,et al. Cancer and fertility preservation: international recommendations from an expert meeting , 2016, BMC Medicine.
[20] L. Boni,et al. Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial. , 2015, JAMA.
[21] S. Loibl,et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] L. Lagae,et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. , 2015, The New England journal of medicine.
[23] C. Denkert,et al. Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients. , 2015, JAMA oncology.
[24] L. Newman,et al. Breast Cancer in Young Women: Rare Disease or Public Health Problem? , 2015, JAMA oncology.
[25] B. Pistilli,et al. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. , 2015, European journal of cancer.
[26] W. Wallace,et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. , 2015, The lancet. Diabetes & endocrinology.
[27] G. Bedoschi,et al. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] N. Biglia,et al. Attitudes on fertility issues in breast cancer patients: an Italian survey , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[29] R. Gelber,et al. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? , 2015, Breast.
[30] M. Lambertini,et al. Targeted agents for cancer treatment during pregnancy. , 2015, Cancer treatment reviews.
[31] J. Forbes,et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. , 2015, The New England journal of medicine.
[32] Y. Englert,et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. , 2014, Human reproduction.
[33] W. Wallace,et al. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation , 2014, The Lancet. Oncology.
[34] S. Paluch-Shimon,et al. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. , 2014, Fertility and sterility.
[35] R. Tamimi,et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] H. Gómez,et al. Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98 , 2014, Psycho-oncology.
[37] S. Linn,et al. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. , 2013, The Cochrane database of systematic reviews.
[38] N. Pavlidis,et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[39] K. Oktay,et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] E. Watson,et al. Fertility preservation in cancer survivors: a national survey of oncologists' current knowledge, practice and attitudes , 2013, British Journal of Cancer.
[41] M. Dimopoulos,et al. Taxanes for breast cancer during pregnancy: a systematic review. , 2013, Clinical breast cancer.
[42] Pietro Panizza,et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. , 2012, European journal of cancer.
[43] T. Fehm,et al. Treatment of breast cancer during pregnancy: an observational study. , 2012, The Lancet. Oncology.
[44] P. Katz,et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer , 2012, Cancer.
[45] G. Bepler,et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] C. Anders,et al. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. , 2007, Fertility and sterility.
[47] M. Lambertini,et al. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. , 2017, European journal of cancer.
[48] R. Gelber,et al. Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. , 2017, Journal of adolescent and young adult oncology.
[49] S. Temin,et al. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2016, Journal of oncology practice / American Society of Clinical Oncology.